Roberts LJ - Search Results

1

Increased CSF F2-isoprostane concentration in probable AD.

Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Among authors: roberts lj. Neurology. 1999 Feb;52(3):562-5. doi: 10.1212/wnl.52.3.562. Neurology. 1999. PMID: 10025788

2

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD. Montine TJ, et al. Among authors: roberts lj 2nd. Ann Neurol. 2002 Aug;52(2):175-9. doi: 10.1002/ana.10272. Ann Neurol. 2002. PMID: 12210787

3

The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist.

Morrow JD, Minton TA, Roberts LJ 2nd. Morrow JD, et al. Among authors: roberts lj 2nd. Prostaglandins. 1992 Aug;44(2):155-63. doi: 10.1016/0090-6980(92)90077-7. Prostaglandins. 1992. PMID: 1438879

4

Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.

Roberts LJ 2nd, Morrow JD. Roberts LJ 2nd, et al. Ann N Y Acad Sci. 1994 Nov 15;744:237-42. doi: 10.1111/j.1749-6632.1994.tb52741.x. Ann N Y Acad Sci. 1994. PMID: 7825845 Review.

5

Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.

Morrow JD, Minton TA, Badr KF, Roberts LJ 2nd. Morrow JD, et al. Among authors: roberts lj 2nd. Biochim Biophys Acta. 1994 Jan 3;1210(2):244-8. doi: 10.1016/0005-2760(94)90128-7. Biochim Biophys Acta. 1994. PMID: 8280777

6

The isoprostanes. Current knowledge and directions for future research.

Morrow JD, Roberts LJ 2nd. Morrow JD, et al. Among authors: roberts lj 2nd. Biochem Pharmacol. 1996 Jan 12;51(1):1-9. doi: 10.1016/0006-2952(95)02072-1. Biochem Pharmacol. 1996. PMID: 8534261 Review.

7

Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans.

Roberts LJ 2nd, Moore KP, Zackert WE, Oates JA, Morrow JD. Roberts LJ 2nd, et al. J Biol Chem. 1996 Aug 23;271(34):20617-20. doi: 10.1074/jbc.271.34.20617. J Biol Chem. 1996. PMID: 8702808 Free article.

8

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Roberts LJ 2nd, et al. J Biol Chem. 1998 May 29;273(22):13605-12. doi: 10.1074/jbc.273.22.13605. J Biol Chem. 1998. PMID: 9593698 Free article.

9

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

Montine TJ, Markesbery WR, Morrow JD, Roberts LJ 2nd. Montine TJ, et al. Among authors: roberts lj 2nd. Ann Neurol. 1998 Sep;44(3):410-3. doi: 10.1002/ana.410440322. Ann Neurol. 1998. PMID: 9749613

10

Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.

Morrow JD, Roberts LJ 2nd. Morrow JD, et al. Among authors: roberts lj 2nd. Methods Enzymol. 1999;300:3-12. doi: 10.1016/s0076-6879(99)00106-8. Methods Enzymol. 1999. PMID: 9919502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters